CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it has appointedCHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it has appointed

ZOLL Medical Appoints Eric Knudsen as New CEO

4 min read

CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it has appointed Eric Knudsen as its new Chief Executive Officer, effective April 1. Knudsen will succeed Jon Rennert, who served as ZOLL’s CEO for the past 10 years and will assume a new role as Executive Chairman of ZOLL’s Board of Directors.

“As a global leader in medical technology, ZOLL is continually looking for ways to expand our business and reach more patients in need,” said Rennert. “Eric has played a unique role in developing our growth strategies and driving our expansion, and I am confident he will lead ZOLL to even greater growth and success.”

“I am honored to become ZOLL’s next CEO,” said Knudsen. “ZOLL has a long legacy of innovation and clinical excellence, and today our medical devices, software, and related services are used worldwide to diagnose and treat patients suffering from serious cardiopulmonary and respiratory conditions. We will continue to lead with our commitment to patients and customers and our passion for improving outcomes and helping save lives.”

Knudsen has nearly 30 years of experience in the medtech industry, with deep expertise in business development and corporate strategy. He led ZOLL’s Corporate Development team for six years and was responsible for investing in strategic relationships and acquiring more than a dozen new technologies.

For the past four years, Knudsen was President of ZOLL Itamar, a division of ZOLL that is focused on the diagnosis of sleep disorders. Knudsen led the division through significant growth and a dramatic increase in profitability.

Prior to joining ZOLL in 2013, Knudsen held leadership positions in international sales, marketing, and manufacturing partnerships at Covidien (now Medtronic), Aspect Medical Systems, and LeMaitre Vascular. He has an MBA from the Thunderbird School of Global Management and a bachelor’s degree from Boston College.

Rennert was named CEO of ZOLL in 2016, after serving as President of the company’s largest business unit for eight years. Under Rennert’s leadership as CEO, ZOLL expanded its reach as a global leader in external defibrillation, pioneered novel solutions for patients with serious cardiopulmonary and respiratory conditions, and significantly broadened its portfolio of products.

About ZOLL
ZOLL, an Asahi Kasei company, develops and markets medical devices and software solutions that help advance care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and cardiac monitoring, circulation enhancement and CPR feedback, supersaturated oxygen therapy, data management, ventilation, therapeutic temperature management, and sleep apnea diagnosis and treatment, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, as well as lay rescuers, improve patient outcomes in critical cardiopulmonary conditions. For more information, visit www.zoll.com.

About Asahi Kasei
The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber businesses, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With 50,000 employees worldwide, the company contributes to a sustainable society by providing solutions to the world’s challenges through its three business sectors of Healthcare, Homes, and Material. Its healthcare operations include devices and systems for critical care, products and services for the manufacture of biotherapeutics, and a growing portfolio of specialty pharmaceuticals. For more information, visit www.asahi-kasei.com.

Asahi Kasei is also dedicated to sustainability initiatives and is contributing to reaching a carbon neutral society by 2050. To learn more, visit https://www.asahi-kasei.com/sustainability/.

Copyright © 2026 ZOLL Medical Corporation. All rights reserved. ZOLL is a registered trademark of ZOLL Medical Corporation and/or its subsidiaries in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All other trademarks are the property of their respective owners.

Contacts

Matt Hogan
ZOLL
978-805-6561
[email protected]

Market Opportunity
Ucan fix life in1day Logo
Ucan fix life in1day Price(1)
$0,0007217
$0,0007217$0,0007217
-5,70%
USD
Ucan fix life in1day (1) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Trading time: Tonight, the US GDP and the upcoming non-farm data will become the market focus. Institutions are bullish on BTC to $120,000 in the second quarter.

Trading time: Tonight, the US GDP and the upcoming non-farm data will become the market focus. Institutions are bullish on BTC to $120,000 in the second quarter.

Daily market key data review and trend analysis, produced by PANews.
Share
PANews2025/04/30 13:50
Ethereum Fusaka Upgrade Set for December 3 Mainnet Launch, Blob Capacity to Double

Ethereum Fusaka Upgrade Set for December 3 Mainnet Launch, Blob Capacity to Double

Ethereum developers confirmed the Fusaka upgrade will activate on mainnet on December 3, 2025, following a systematic testnet rollout beginning on October 1 on Holesky. The major hard fork will implement around 11-12 Ethereum Improvement Proposals targeting scalability, node efficiency, and data availability improvements without adding new user-facing features. According to Christine Kim, the upgrade introduces a phased blob capacity expansion through Blob Parameter Only forks occurring two weeks after Fusaka activation. Initially maintaining current blob limits of 6/9 target/max, the first BPO fork will increase capacity to 10/15 blobs one week later. A second BPO fork will further expand limits to 14/21 blobs, more than doubling total capacity within two weeks. Strategic Infrastructure Overhaul Fusaka prioritizes backend protocol improvements over user-facing features, focusing on making Ethereum faster and less resource-intensive. The upgrade includes PeerDAS implementation through EIP-7594, allowing validator nodes to verify data by sampling small pieces rather than downloading entire blobs. This reduces bandwidth and storage requirements while enhancing Layer 2 rollup scalability. The upgrade builds on recent gas limit increases from 30 million to 45 million gas, with ongoing discussions for further expansion. EIP-7935 proposes increasing limits to 150 million gas, potentially enabling significantly higher transaction throughput. These improvements complement broader scalability efforts, including EIP-9698, which suggests a 100x gas limit increase over two years to reach 2,000 transactions per second. Fusaka removes the previously planned EVM Object Format redesign to reduce complexity while maintaining focus on essential infrastructure improvements. The upgrade introduces bounded base fees for blob transactions via EIP-7918, creating more predictable transaction costs for data-heavy applications. Enhanced spam resistance and security improvements strengthen network resilience against scalability bottlenecks and attacks. Technical Implementation and Testing Timeline The Fusaka rollout follows a conservative four-phase approach across Ethereum testnets before mainnet deployment. Holesky upgrade occurs October 1, followed by Sepolia on October 14 and Hoodi on October 28. Each testnet will undergo the complete BPO fork sequence to validate the blob capacity expansion mechanism. BPO forks activate automatically based on predetermined epochs rather than requiring separate hard fork processes. On mainnet, the first BPO fork launches December 17, increasing blob capacity to 10/15 target/max. The second BPO fork activates January 7, 2026, reaching the final capacity of 14/21 blobs. This automated approach enables flexible blob scaling without requiring full network upgrades. Notably, node operators face release deadlines ranging from September 25 for Holesky to November 3 for mainnet preparation. The staggered timeline, according to the developers, allows comprehensive testing while giving infrastructure providers sufficient preparation time. Speculatively, the developers use this backward-compatible approach to ensure smooth transitions with minimal disruption to existing applications. PeerDAS implementation reduces node resource demands, potentially increasing network decentralization by lowering barriers for smaller operators. The technology enables more efficient data availability sampling, crucial for supporting growing Layer 2 rollup adoption. Overall, these improvements, combined with increased gas limits, will enable Ethereum to handle higher transaction volumes while maintaining security guarantees. Addressing Network Scalability Pressures The Fusaka upgrade addresses mounting pressure for Ethereum base layer improvements amid criticism of Layer 2 fragmentation strategies. Critics argue that reliance on rollups has created isolated chains with limited interoperability, complicating user experiences. The upgrade’s focus on infrastructure improvements aims to enhance base layer capacity while supporting continued Layer 2 growth. The recent validator queue controversy particularly highlights ongoing network scalability challenges. According to a Cryptonews report covered yesterday, currently, over 2M ETH sits in exit queues facing 43-day delays, while entry queues process in just 7 days.Ethereum Validator Queue (Source: ValidatorQueue) However, Vitalik Buterin defended these delays as essential for network security, comparing validator commitments to military service requiring “friction in quitting.” The upgrade coincides with growing institutional interest in Ethereum infrastructure, with VanEck predicting that Layer 2 networks could reach $1 trillion market capitalization within six years. Fusaka’s emphasis on data availability and node efficiency supports Ethereum’s evolution toward seamless cross-chain interoperability. The upgrade complements initiatives like the Open Intents Framework, where Coinbase Payments recently joined as a core contributor. The initiative, if successful, will address the $21B surge in cross-chain crime. These coordinated efforts aim to unify the fragmented multichain experience while maintaining Ethereum’s security and decentralization principles
Share
CryptoNews2025/09/19 16:37
VectorUSA Achieves Fortinet’s Engage Preferred Services Partner Designation

VectorUSA Achieves Fortinet’s Engage Preferred Services Partner Designation

TORRANCE, Calif., Feb. 3, 2026 /PRNewswire/ — VectorUSA, a trusted technology solutions provider, specializes in delivering integrated IT, security, and infrastructure
Share
AI Journal2026/02/05 00:02